000			02239cam a2200349 a 4500
003			EG-GiCUC
005			20250223031206.0
008			150331s2014 ua d f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aPh.D
099			_aCai01.11.33.Ph.D.2014.Ba.H
100	0		_aBasem Elsayed Eysa Elsayed
245	1	0	_aHistopathological findings in liver biopsy in relation to virological response in chronic hepatitis C patients Receiving combined therapy / _cBasem Elsayed Eysa Elsayed ; Supervised Gamal Eldin Esmat , Wahid Halim Doss , Ehsan Hassan Hassan
246	1	5	_aالتغيرات المرضية في العينات الكبدية ومدي تأثيرھا علي الاستجابة للعلاج المزدوج للمرضي المصابين بفيروس (س) المزمن
260			_aCairo : _bBasem Elsayed Eysa Elsayed , _c2014
300			_a103 P. : _bcharts ; _c25cm
502			_aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
520			_aIn conclusion, considering the value and safety of LB, and the current limitations of noninvasive tests, LB will continue to remain, in the nearby future, as the cornerstone and the gold standard test in the assessment of liver fibrosis and histology. Accordingly, treatment decision in less developed countries should be tailored to attain the highest cost effective disease outcome. While great efforts and advances have been made to improve noninvasive markers, nevertheless, major steps remain ahead before these tests can replace LB in both the information obtained and the accuracy in diagnosis. The relapse of patients could be predicted pretreatment by good patient selection, as well as patient sustained virological response
530			_aIssued also as CD
653		4	_aAssessment of liver tissue
653		4	_aChronic hepatitis C
653		4	_aHepatitis C Overview
700	0		_aEhsan Hassan Hassan , _eSupervisor
700	0		_aGamal Eldin Esmat , _eSupervisor
700	0		_aWahid Halim Doss , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aAml _eCataloger
905			_aNazla _eRevisor
942			_2ddc _cTH
999			_c50180 _d50180